SCHEMBL3467962

SCHEMBL3467962

COc1ccccc1-c1ccc(CCC(CCCc2ccccc2)C(=O)O)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.54
PPARA Q07869 1/20 0.54
SLC13A5 Q86YT5 1/20 0.52
LPAR1 Q92633 2/20 0.49
FFAR1 O14842 2/20 0.48
ITGA4 P13612 2/20 0.47
ITGB7 P26010 2/20 0.47
GRIK1 P39086 1/20 0.47
ITGB1 P05556 1/20 0.47
PDE4A P27815 3/20 0.46
PDE4B Q07343 3/20 0.46
PDE4C Q08493 3/20 0.46
PDE4D Q08499 3/20 0.46
PTGES O14684 1/20 0.46
ALOX5 P09917 1/20 0.46
MME P08473 1/20 0.46
MMEL1 Q495T6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3466555 0.91 LPAR1 (0.50) PPARGPPARASLC13A5LPAR1FFAR1
SCHEMBL3467371 0.84 MMP3 (0.58) GRIK1PDE4APDE4BPDE4CPDE4D
SCHEMBL7918302 0.83 MAPK1 (0.46) PPARGSLC13A5FFAR1GRIK1PTGES
SCHEMBL3467355 0.82 GRIK1 (0.51) GRIK1MME
SCHEMBL1856418 0.82 ALDH1A1 (0.56) GRIK1PDE4APDE4BPDE4CPDE4D
SCHEMBL1861903 0.81 GRIK1 (0.59) FFAR1GRIK1MME
SCHEMBL7446944 0.81 SLC13A5 (0.55) PPARGPPARASLC13A5FFAR1ITGA4
SCHEMBL7923945 0.81 MMP2 (0.57) PPARGPPARAFFAR1GRIK1MME
SCHEMBL1860416 0.80 GRIK1 (0.68) PPARGPPARAGRIK1PTGESALOX5
SCHEMBL7236617 0.79 SLC13A5 (0.62) PPARGPPARASLC13A5LPAR1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO claimed
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed